Abstract
The steroid hormone progesterone (P4) is essential for establishing and maintaining pregnancy in mammals1,2,3. One of its functions includes maintenance of uterine quiescence by decreasing uterine sensitivity to the uterotonic peptide hormone oxytocin3,4,5. Although it is generally held that steroid hormones such as P4 act at a genomic level by binding to nuclear receptors and modulating the expression of specific target genes6, we show here that the effect of P4 on uterine sensitivity to oxytocin involves direct, non-genomic action of P4 on the uterine oxytocin receptor (OTR), a member of the G-protein-coupled receptor family. P4 inhibits oxytocin binding to OTR-containing membranes in vitro, binds with high affinity to recombinant rat OTR expressed in CHO cells, and suppresses oxytocin-induced inositol phosphate production and calcium mobilization. These effects are highly steroid- and receptor-specific, because binding and signalling functions of the closely related human OTR are not affected by P4 itself but by the P4 metabolite 5β-dihydroprogesterone. Our findings provide the first evidence for a direct interaction between a steroid hormone and a G-protein-coupled receptor and define a new level of crosstalk between the peptide- and steroid-hormone signalling pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Csapo, A. I., Puri, C. P. & Tarro, S. Relationship between timing of ovariectomy and maintenance of pregnancy in the guinea-pig. Prostaglandins 22, 131–140 (1981).
Pepe, G. J. & Albrecht, E. D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr. Rev. 16, 608–648 (1995).
Garfield, R. E., Puri, C. P. & Csapo, A. I. Endocrine, structural, and functional changes in the uterus during premature labor. Am. J. Obstet. Gynecol. 142, 21–27 (1982).
Fuchs, A. R., Periyasamy, S., Alexandrova, M. & Soloff, M. S. Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium: effects of ovarian steroids. Endocrinology 113, 742–749 (1983).
Soloff, M. S. et al. Regulation of oxytocin receptor concentration in rat uterine explants by estrogen and progesterone. Can. J. Biochem. Cell Biol. 61, 625–630 (1983).
Tsai, M. J. & O'Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451–486 (1994).
Larcher, A. et al. Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. Endocrinology 136, 5350–5356 (1995).
Elands, J. et al.125I-labelled d(CH2)5[Tyr(Me)2, Thr4, Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand. Eur. J. Pharmacol. 147, 197–207 (1988).
Pepe, G. J. & Rothchild, I. Acomparative study of serum progesterone levels in pregnancy and in various types of pseudopregnancy in the rat. Endocrinology 95, 275–279 (1974).
Schmidt, A. et al. Aradioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors. FEBS Lett. 282, 77–81 (1991).
Zingg, H. H. in Bailliere's Clinical Endocrinology and Metabolism (eds Sheppard, M. C. & Franklyn, J.A.) 75–96 (Bailliere Tindall, London, (1996)).
Burgisser, E., De Lean, A. & Lefkowitz, R. J. Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Proc. Natl Acad. Sci. USA 79, 1732–1736 (1982).
Green, R. D. Reciprocal modulation of agonist and antagonist binding to inhibitory adenosine receptors by 5′-guanylylimidodiphosphate and monovalent cations. J. Neurosci. 4, 2472–2476 (1984).
Sundaram, H., Newman-Tancredi, A. & Strange, P. G. Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 45, 1003–1009 (1993).
Westphal, R. S. & Sanders-Bush, E. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol. Pharmacol. 46, 937–942 (1994).
Grazzini, E. et al. Membrane-delimited G protein-mediated coupling between V1a vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells. Mol. Pharmacol. 50, 1273–1283 (1996).
Wassermann, W. J., Pinto, L. H., O'Connor, C. M. & Smith, L. D. Progesterone induces a rapid increase in [Ca2+]inof Xenopus laevis oocytes. Proc. Natl Acad. Sci. USA 77, 1534–1536 (1980).
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L. & Paul, S. M. Steroid hormone metabolites are barbituarate-like modulators of the GABA receptor. Science 232, 1004–1007 (1986).
Wong, M. & Moss, R. L. Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J. Neuroendocrinol. 6, 347–355 (1994).
Valera, S., Ballivet, M. & Bertrand, D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl Acad. Sci. USA 89, 9949–9953 (1992).
Blackmore, P. F., Fisher, J. F., Spilman, C. H. & Bleasdale, J. E. Unusual steroid specificity of the cell surface progesterone receptor on human sperm. Mol. Pharmacol. 49, 727–739 (1996).
Schumacher, M., Coirini, H., Frankfurt, M. & McEwen, B. S. Localized actions of progesterone in hypothalamus involve oxytocin. Proc. Natl Acad. Sci. USA 86, 6798–6801 (1989).
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M. J. & Okayama, H. Structure and expression of a human oxytocin receptor. Nature 356, 526–529 (1992).
Chini, B. et al. Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J. 14, 2176–2182 (1995).
Grazzini, E. et al. Dual effects of fluoro-aluminate on activation of calcium influx and inhibition of agonist-induced calcium mobilization in rat glomerulosa cells. Cell Calcium 19, 29–41 (1996).
Guillon, G. et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology 136, 1285–1295 (1995).
Jeng, Y. J. et al. Molecular cloning and functional characterization of the oxytocin receptor from a rat pancreatic cell line (RINm5F). Neuropeptides 30, 557–65 (1996).
Acknowledgements
We thank S. Jard, M. Bouvier and A. DeLean for discussion and for comments, N.Gallo-Payet and D. Payet for help with calcium measurements, J. Neculcea for technical help and E.Monaco for secretarial assistance. This research was supported from grants by the MRC of Canada. E.G. is supported by an MRC Fellowship award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grazzini, E., Guillon, G., Mouillac, B. et al. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392, 509–512 (1998). https://doi.org/10.1038/33176
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/33176
This article is cited by
-
Machine learning analysis predicts a person’s sex based on mechanical but not thermal pain thresholds
Scientific Reports (2023)
-
Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function
Cellular and Molecular Life Sciences (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.